News ConvaTec looks to support UK wound care through sector deal Wound care specialist ConvaTec has welcomed the UK government's Sector Deal for wound care and set out how it plans to support the country’s industry going forward.
News Taiho's late-stage Duchenne candidate fails trial Taiho has suffered a blow to its near-term pipeline after a drug candidate for Duchenne muscular dystrophy (DMD) missed the mark in a phase 3 trial.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face